The present study constructed prediction models for 2-year mortality of metastatic ovarian cancer patients based on the predictors including age, radiation therapy, surgery and chemotherapy, CA125, bone metastasis, brain metastasis, liver metastasis, and lung metastasis. The gene discussed is MUC16; the disease is bone metastasis.